HH BIOTECHNOLOGY HOLDINGS CO·3

Jan 11, 12:22 PM ET

HH BIOTECHNOLOGY HOLDINGS CO 3

3 · HH BIOTECHNOLOGY HOLDINGS CO · Filed Jan 11, 2017

Insider Transaction Report

Form 3
Period: 2016-09-09
Wang Lirong
Chief Financial Officer
Holdings
  • Common Stock

    91,024

Documents

1 file
  • 3
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT